Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) FCF Margin (2016 - 2026)

Apyx Medical filings provide 15 years of FCF Margin readings, the most recent being 14.64% for Q4 2025.

  • On a quarterly basis, FCF Margin rose 774.0% to 14.64% in Q4 2025 year-over-year; TTM through Dec 2025 was 17.25%, a 2177.0% increase, with the full-year FY2025 number at 17.25%, up 2177.0% from a year prior.
  • FCF Margin hit 14.64% in Q4 2025 for Apyx Medical, up from 31.49% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 29.41% in Q3 2023 to a low of 62.24% in Q1 2024.
  • Median FCF Margin over the past 5 years was 31.7% (2021), compared with a mean of 28.51%.
  • Biggest five-year swings in FCF Margin: surged 12405bps in 2021 and later crashed -6939bps in 2024.
  • Apyx Medical's FCF Margin stood at 0.7% in 2021, then tumbled by -5182bps to 37.05% in 2022, then skyrocketed by 58bps to 15.72% in 2023, then tumbled by -42bps to 22.37% in 2024, then surged by 35bps to 14.64% in 2025.
  • The last three reported values for FCF Margin were 14.64% (Q4 2025), 31.49% (Q3 2025), and 13.17% (Q2 2025) per Business Quant data.